Bio-Techne Insider Trades
NASDAQ: TECHHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 2 · $437.18K
- Shares bought / sold
- 0 / 8.61K
- Net activity
- Net selling $437,178
Bio-Techne insider activity
Over the last 12 months, Bio-Techne insiders reported 66 transactions on SEC Form 4: 0 open-market purchases and 2 sales. Insiders bought $0 and sold $437,178 worth of stock, for net insider selling of $437,178. The largest seller was Herr Amy E., with $437,178 in reported sales.
The most recent filing shows Kelderman Kim (Chief Executive Officer) reporting a transaction in 2,385 shares at $72.66 on Nov 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put TECH's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
TECH insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 1, 2026 | Hippel JamesCFO | Tax withholding | 5,096 | $370.28K | Form 4 |
| Nov 1, 2026 | Hippel JamesCFO | Option exercise | 11,545 | — | Form 4 |
| Nov 1, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 2,385 | $173.29K | Form 4 |
| Oct 29, 2026 | BAUMGARTNER ROBERT VDirector | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | Bushman Julie LDirector | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | HIGGINS JOHN LDirector | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | KEEGAN JOSEPH DDirector | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | Klimovsky Judith V.Director | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | Herr Amy E.Director | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | Seth AlpnaDirector | Award | 2,750 | — | Form 4 |
| Oct 29, 2026 | Vessey RupertDirector | Award | 2,750 | — | Form 4 |
| Sep 28, 2026 | HIGGINS JOHN LDirector | Tax withholding | 5,562 | $403.30K | Form 4 |
| Sep 28, 2026 | HIGGINS JOHN LDirector | Option exercise | 15,940 | — | Form 4 |
| Sep 22, 2026 | BAUMGARTNER ROBERT VDirector | Tax withholding | 5,559 | $403.31K | Form 4 |
| Sep 22, 2026 | BAUMGARTNER ROBERT VDirector | Option exercise | 15,940 | — | Form 4 |
| Aug 15, 2026 | Herr Amy E.Director | Tax withholding | 213 | $15.42K | Form 4 |
| Aug 15, 2026 | Herr Amy E.Director | Option exercise | 589 | — | Form 4 |
| Aug 15, 2026 | Crouse Steven C.President - Diag & Spatial Bi | Tax withholding | 1,947 | $140.96K | Form 4 |
| Aug 15, 2026 | Crouse Steven C.President - Diag & Spatial Bi | Option exercise | 5,423 | — | Form 4 |
| Aug 15, 2026 | Bohnen ShaneSVP - General Counsel | Tax withholding | 1,343 | $97.23K | Form 4 |
| Aug 15, 2026 | Bohnen ShaneSVP - General Counsel | Option exercise | 4,350 | — | Form 4 |
| Aug 15, 2026 | Geist WilliamPRESIDENT, PROTEIN SCIENCES | Tax withholding | 1,976 | $143.06K | Form 4 |
| Aug 15, 2026 | Geist WilliamPRESIDENT, PROTEIN SCIENCES | Option exercise | 6,416 | — | Form 4 |
| Aug 15, 2026 | Hippel JamesCFO | Tax withholding | 4,310 | $312.04K | Form 4 |
| Aug 15, 2026 | Hippel JamesCFO | Option exercise | 9,779 | — | Form 4 |
| Aug 15, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 10,821 | $783.44K | Form 4 |
| Aug 15, 2026 | Kelderman KimChief Executive Officer | Option exercise | 21,470 | — | Form 4 |
| Aug 15, 2026 | Hippel JamesCFO | Tax withholding | 4,423 | $320.23K | Form 4 |
| Aug 15, 2026 | Hippel JamesCFO | Option exercise | 9,980 | — | Form 4 |
| Aug 15, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 10,955 | $793.14K | Form 4 |
| Aug 15, 2026 | Kelderman KimChief Executive Officer | Option exercise | 21,736 | — | Form 4 |
| Aug 15, 2026 | Bohnen ShaneSVP - General Counsel | Tax withholding | 1,366 | $98.90K | Form 4 |
| Aug 15, 2026 | Bohnen ShaneSVP - General Counsel | Option exercise | 4,420 | — | Form 4 |
| Aug 15, 2026 | Geist WilliamPRESIDENT, PROTEIN SCIENCES | Tax withholding | 2,019 | $146.18K | Form 4 |
| Aug 15, 2026 | Geist WilliamPRESIDENT, PROTEIN SCIENCES | Option exercise | 6,547 | — | Form 4 |
| Jul 29, 2026 | Hippel JamesCFO | Tax withholding | 51,024 | $3.68M | Form 4 |
| Jul 29, 2026 | Hippel JamesCFO | Option exercise | 62,068 | $2.95M | Form 4 |
| Jul 28, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 28,686 | $2.07M | Form 4 |
| Jul 28, 2026 | Kelderman KimChief Executive Officer | Option exercise | 35,000 | $1.67M | Form 4 |
| Jul 23, 2026 | Bohnen ShaneSVP - General Counsel | Tax withholding | 344 | $24.69K | Form 4 |
| Jul 23, 2026 | Bohnen ShaneSVP - General Counsel | Option exercise | 448 | $21.32K | Form 4 |
| Jun 2, 2026 | Crouse Steven C.President - Diag & Spatial Bi | Tax withholding | 216 | $10.75K | Form 4 |
| Jun 2, 2026 | Crouse Steven C.President - Diag & Spatial Bi | Option exercise | 600 | — | Form 4 |
| May 8, 2026 | Herr Amy E.Director | Sale | 6,636 | $320.39K | Form 4 |
| May 8, 2026 | Herr Amy E.Director | Option exercise | 6,636 | $315.87K | Form 4 |
| May 5, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 23,951 | $1.36M | Form 4 |
| May 5, 2026 | Kelderman KimChief Executive Officer | Option exercise | 26,692 | $1.27M | Form 4 |
| May 5, 2026 | Hippel JamesCFO | Tax withholding | 56,955 | $3.23M | Form 4 |
| May 5, 2026 | Hippel JamesCFO | Option exercise | 62,000 | $2.95M | Form 4 |
| May 5, 2026 | Bohnen ShaneSVP - General Counsel | Tax withholding | 7,055 | $399.88K | Form 4 |
| May 5, 2026 | Bohnen ShaneSVP - General Counsel | Option exercise | 8,400 | $399.84K | Form 4 |
| May 1, 2026 | Crouse Steven C.President - Diag & Spatial Bi | Tax withholding | 311 | $17.11K | Form 4 |
| May 1, 2026 | Crouse Steven C.President - Diag & Spatial Bi | Option exercise | 794 | — | Form 4 |
| Apr 22, 2026 | Hippel JamesCFO | Tax withholding | 56,097 | $3.29M | Form 4 |
| Apr 22, 2026 | Hippel JamesCFO | Option exercise | 62,000 | — | Form 4 |
| Apr 22, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 1,363 | $79.84K | Form 4 |
| Apr 22, 2026 | Kelderman KimChief Executive Officer | Option exercise | 11,344 | — | Form 4 |
| Apr 14, 2026 | Kelderman KimChief Executive Officer | Tax withholding | 32,088 | $1.88M | Form 4 |
| Apr 14, 2026 | Kelderman KimChief Executive Officer | Option exercise | 36,500 | — | Form 4 |
| Apr 3, 2026 | Bohnen ShaneSVP - General Counsel | Tax withholding | 740 | $39.32K | Form 4 |
| Apr 3, 2026 | Bohnen ShaneSVP - General Counsel | Option exercise | 2,259 | — | Form 4 |
| Feb 17, 2026 | Herr Amy E.Director | Sale | 1,976 | $116.79K | Form 4 |
| Feb 3, 2026 | Herr Amy E.Director | Tax withholding | 16 | $1.03K | Form 4 |
| Feb 3, 2026 | Herr Amy E.Director | Option exercise | 38 | — | Form 4 |
| Feb 1, 2026 | McManus MatthewPresident - Diag & Spatial Bio | Tax withholding | 1,665 | $106.71K | Form 4 |
| Feb 1, 2026 | McManus MatthewPresident - Diag & Spatial Bio | Option exercise | 4,621 | — | Form 4 |
| Nov 3, 2025 | Hippel JamesCFO | Tax withholding | 11,865 | $742.39K | Form 4 |
| Nov 3, 2025 | Hippel JamesCFO | Option exercise | 11,545 | — | Form 4 |
| Nov 3, 2025 | Hippel JamesCFO | Option exercise | 13,159 | — | Form 4 |
| Nov 3, 2025 | Kelderman KimChief Executive Officer | Tax withholding | 2,303 | $144.10K | Form 4 |
| Nov 3, 2025 | Geist WilliamPRESIDENT, PROTEIN SCIENCES | Tax withholding | 4,520 | $282.82K | Form 4 |
| Nov 3, 2025 | Geist WilliamPRESIDENT, PROTEIN SCIENCES | Option exercise | 9,911 | — | Form 4 |
| Oct 30, 2025 | Herr Amy E.Director | Award | 1,640 | — | Form 4 |
| Oct 30, 2025 | Seth AlpnaDirector | Award | 1,640 | — | Form 4 |
| Oct 30, 2025 | HIGGINS JOHN LDirector | Award | 1,640 | — | Form 4 |
| Oct 30, 2025 | Klimovsky Judith V.Director | Award | 1,640 | — | Form 4 |
| Oct 30, 2025 | Bushman Julie LDirector | Award | 1,640 | — | Form 4 |
| Oct 30, 2025 | KEEGAN JOSEPH DDirector | Award | 1,640 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4